{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:38:17Z","timestamp":1791326297877,"version":"4.3.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The presence of lateral pelvic lymph node (LLN) metastasis is an essential prognostic factor in rectal cancer patients. Thus, preoperative diagnosis of LLN metastasis is clinically important to determine the therapeutic strategy. The aim of this study was to evaluate the efficacy of preoperative positron emission tomography\/computed tomography (PET\/CT) in the diagnosis of LLN metastasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eighty-four patients with rectal cancer who underwent LLN dissection at Osaka University were included in this study. The maximum standardized uptake value (SUV<jats:sub>max<\/jats:sub>) of the primary tumor and LLN were preoperatively calculated using PET\/CT. Simultaneously, the short axis of the lymph node was measured using multi-detector row computed tomography (MDCT). The presence of metastases was evaluated by postoperative pathological examination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 84 patients, LLN metastases developed in the left, right, and both LLN regions in 6, 7, and 2 patients, respectively. The diagnosis of the metastases was predicted with a sensitivity of 82%, specificity of 93%, positive predictive value of 58%, negative predictive value of 98%, false positive value of 7%, and false negative value of 18% when the cutoff value of the LLN SUV<jats:sub>max<\/jats:sub> was set at 1.5. The cutoff value of the short axis set at 7\u2009mm on MDCT was most useful in diagnosing LLN metastases, but SUV<jats:sub>max<\/jats:sub> was even more useful in terms of specificity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The cutoff value of 1.5 for lymph node SUV<jats:sub>max<\/jats:sub> in PET is a reasonable measure to predict the risk of preoperative LLN metastases in rectal cancer patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08278-6","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T01:05:29Z","timestamp":1620435929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Ryohei","family":"Yukimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsuboyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiki","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikatsu","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Furuyashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"2","key":"8278_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00000658-198602000-00001","volume":"203","author":"N Wolmark","year":"1986","unstructured":"Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the dukes\u2019 C class of colorectal cancer. An analysis of the NSABP clinical trials. Ann Surg. 1986;203(2):115\u201322. https:\/\/doi.org\/10.1097\/00000658-198602000-00001.","journal-title":"Ann Surg"},{"issue":"6","key":"8278_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W Van Gijn","year":"2011","unstructured":"Van Gijn W, Marijnen CAM, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(11)70097-3.","journal-title":"Lancet Oncol."},{"issue":"11","key":"8278_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1470-2045(09)70224-4","volume":"10","author":"P Georgiou","year":"2009","unstructured":"Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009;10(11):1053\u201362. https:\/\/doi.org\/10.1016\/S1470-2045(09)70224-4.","journal-title":"Lancet Oncol."},{"issue":"7","key":"8278_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s002689900298","volume":"21","author":"Y Moriya","year":"1997","unstructured":"Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg. 1997;21(7):728\u201332. https:\/\/doi.org\/10.1007\/s002689900298.","journal-title":"World J Surg"},{"issue":"1","key":"8278_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/01.sla.0000225359.72553.8c","volume":"245","author":"H Ueno","year":"2007","unstructured":"Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, et al. Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg. 2007;245(1):80\u20137. https:\/\/doi.org\/10.1097\/01.sla.0000225359.72553.8c.","journal-title":"Ann Surg"},{"issue":"11","key":"8278_CR6","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s10350-006-0714-z","volume":"49","author":"K Sugihara","year":"2006","unstructured":"Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006;49(11):1663\u201372. https:\/\/doi.org\/10.1007\/s10350-006-0714-z.","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"8278_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/SLA.0000000000002212","volume":"266","author":"S Fujita","year":"2017","unstructured":"Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II\/III lower rectal Cancer (JCOG0212): a multicenter, randomized controlled. Noninferiority Trial Ann Surg. 2017;266(2):201\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000002212.","journal-title":"Noninferiority Trial Ann Surg"},{"issue":"9","key":"8278_CR8","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/BF02234784","volume":"44","author":"H Nagawa","year":"2001","unstructured":"Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum. 2001;44(9):1274\u201380. https:\/\/doi.org\/10.1007\/BF02234784.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"8278_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S1470-2045(12)70158-4","volume":"13","author":"S Fujita","year":"2012","unstructured":"Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012;13(6):616\u201321. https:\/\/doi.org\/10.1016\/S1470-2045(12)70158-4.","journal-title":"Lancet Oncol"},{"issue":"10","key":"8278_CR10","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1245\/s10434-009-0613-3","volume":"16","author":"T Akasu","year":"2009","unstructured":"Akasu T, Iinuma G, Takawa M, Yamamoto S, Muramatsu Y, Moriyama N. Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer. Ann Surg Oncol. 2009;16(10):2787\u201394. https:\/\/doi.org\/10.1245\/s10434-009-0613-3.","journal-title":"Ann Surg Oncol"},{"issue":"5B","key":"8278_CR11","first-page":"3529","volume":"27","author":"H Matsuoka","year":"2007","unstructured":"Matsuoka H, Nakamura A, Masaki T, Sugiyama M, Nitatori T, Ohkura Y, et al. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res. 2007;27(5B):3529\u201333.","journal-title":"Anticancer Res"},{"issue":"1","key":"8278_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1200\/JCO.18.00032","volume":"37","author":"A Ogura","year":"2019","unstructured":"Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. Neoadjuvant (chemo) radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: result of the multicenter lateral node study of patients with low cT3\/4 rectal cancer. J Clin Oncol. 2019;37(1):33\u201343. https:\/\/doi.org\/10.1200\/JCO.18.00032.","journal-title":"J Clin Oncol"},{"issue":"2","key":"8278_CR13","first-page":"224","volume":"53","author":"D Vriens","year":"2009","unstructured":"Vriens D, de Geus-Oei LF, van der Graaf WT, Oyen WJ. Tailoring therapy in colorectal cancer by PET-CT. Q J Nucl Med Mol Imaging. 2009;53(2):224\u201344.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"2","key":"8278_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10147-019-01557-0","volume":"25","author":"A Watanabe","year":"2020","unstructured":"Watanabe A, Harimoto N, Yokobori T, Araki K, Kubo N, Igarashi T, et al. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis. Int J Clin Oncol. 2020;25(2):322\u20139. https:\/\/doi.org\/10.1007\/s10147-019-01557-0.","journal-title":"Int J Clin Oncol"},{"issue":"Suppl 3","key":"8278_CR15","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.1245\/s10434-014-3572-2","volume":"21","author":"T Ogino","year":"2014","unstructured":"Ogino T, Takemasa I, Horitsugi G, Furuyashiki M, Ohta K, Uemura M, et al. Preoperative evaluation of venous anatomy in laparoscopic complete mesocolic excision for right colon cancer. Ann Surg Oncol. 2014 Jun;21(Suppl 3):S429\u201335. https:\/\/doi.org\/10.1245\/s10434-014-3572-2.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"8278_CR16","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1245\/s10434-009-0692-1","volume":"16","author":"BS Min","year":"2009","unstructured":"Min BS, Kim JS, Kim NK, Lim JS, Lee KY, Cho CH, et al. Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. Ann Surg Oncol. 2009;16(12):3271\u20138. https:\/\/doi.org\/10.1245\/s10434-009-0692-1.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"8278_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1245\/ASO.2006.04.042","volume":"13","author":"SL Gearhart","year":"2006","unstructured":"Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography\/computed tomography in low rectal cancer. Ann Surg Oncol. 2006;13(3):397\u2013404. https:\/\/doi.org\/10.1245\/ASO.2006.04.042.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"8278_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00423-006-0066-0","volume":"391","author":"K Arii","year":"2006","unstructured":"Arii K, Takifuji K, Yokoyama S, Matsuda K, Higashiguchi T, Tominaga T, et al. Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and MDCT in 53 patients. Langenbeck's Arch Surg. 2006;391(5):449\u201354. https:\/\/doi.org\/10.1007\/s00423-006-0066-0.","journal-title":"Langenbeck's Arch Surg"},{"issue":"4","key":"8278_CR19","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00268-015-3299-7","volume":"40","author":"A Ishibe","year":"2016","unstructured":"Ishibe A, Ota M, Watanabe J, Suwa Y, Suzuki S, Kanazawa A, et al. Prediction of lateral pelvic lymph-node metastasis in low rectal Cancer by magnetic resonance imaging. World J Surg. 2016;40(4):995\u20131001. https:\/\/doi.org\/10.1007\/s00268-015-3299-7.","journal-title":"World J Surg"},{"key":"8278_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.23922\/jarc.2019-022","volume":"4","author":"K Amano","year":"2020","unstructured":"Amano K, Fukuchi M, Kumamoto K, Hatano S, Ohno H, Osada H, et al. Pre-operative Evaluation of Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer: Comparison of Three Different Imaging Modalities. J Anus Rectum Colon. 2020;4:34\u201340. https:\/\/doi.org\/10.23922\/jarc.2019-022.","journal-title":"J Anus Rectum Colon"},{"issue":"2","key":"8278_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiol.2272011747","volume":"227","author":"G Brown","year":"2003","unstructured":"Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227(2):371\u20137. https:\/\/doi.org\/10.1148\/radiol.2272011747.","journal-title":"Radiology."},{"key":"8278_CR22","doi-asserted-by":"publisher","first-page":"5439378","DOI":"10.1155\/2020\/5439378","volume":"2020","author":"H Dahmarde","year":"2020","unstructured":"Dahmarde H, Parooie F, Salarzaei M. Is [ 18F ] FDG pet \/ Ct an accurate way to detect lymph node metastasis in colorectal Cancer : a systematic review and meta-analysis. Contrast Media Mol Imaging. 2020;2020:5439378\u201311. https:\/\/doi.org\/10.1155\/2020\/5439378.","journal-title":"Contrast Media Mol Imaging"},{"issue":"5","key":"8278_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jjco\/hyn032","volume":"38","author":"Y Tsunoda","year":"2008","unstructured":"Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET\/CT. Jpn J Clin Oncol. 2008;38(5):347\u201353. https:\/\/doi.org\/10.1093\/jjco\/hyn032.","journal-title":"Jpn J Clin Oncol"},{"key":"8278_CR24","doi-asserted-by":"publisher","first-page":"5802109","DOI":"10.1155\/2018\/5802109","volume":"2018","author":"R Chen","year":"2018","unstructured":"Chen R, Wang Y, Zhou X, Huang G, Liu J. Preoperative PET\/CT 18F-FDG standardized uptake by lymph nodes as a significant prognostic factor in patients with colorectal cancer. Contrast Media Mol Imaging. 2018;2018:5802109\u20137. https:\/\/doi.org\/10.1155\/2018\/5802109.","journal-title":"Contrast Media Mol Imaging."},{"issue":"5","key":"8278_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10151-018-1779-0","volume":"22","author":"S Ishihara","year":"2018","unstructured":"Ishihara S, Kawai K, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, et al. Diagnostic value of FDG-PET\/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Tech Coloproctol. 2018;22(5):347\u201354. https:\/\/doi.org\/10.1007\/s10151-018-1779-0.","journal-title":"Tech Coloproctol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08278-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T01:05:49Z","timestamp":1620435949000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08278-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8278"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08278-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed following the Declaration of Helsinki and Good Clinical Practice Guidelines, and All patients provided written informed consent before any form of clinical examination.This retrospective study was approved by the Research Ethics Committee of Osaka University (approval ID: 12418\u20136).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"520"}}